Pages that link to "Q37854284"
Jump to navigation
Jump to search
The following pages link to The host immune response to Clostridium difficile (Q37854284):
Displaying 50 items.
- Gastrointestinal dysbiosis and the use of fecal microbial transplantation in Clostridium difficile infection (Q26776155) (← links)
- Clostridium difficile Infection in Children: Current State and Unanswered Questions (Q27016320) (← links)
- Asymptomatic Clostridium difficile colonization: epidemiology and clinical implications (Q28083860) (← links)
- Older Is Not Wiser, Immunologically Speaking: Effect of Aging on Host Response to Clostridium difficile Infections (Q30251941) (← links)
- Role of leptin-mediated colonic inflammation in defense against Clostridium difficile colitis (Q30412148) (← links)
- Immune responses to Clostridium difficile infection (Q30416692) (← links)
- Functional genomics reveals that Clostridium difficile Spo0A coordinates sporulation, virulence and metabolism (Q33641301) (← links)
- Calprotectin and lactoferrin faecal levels in patients with Clostridium difficile infection (CDI): a prospective cohort study (Q34110399) (← links)
- Clostridium difficile infection in the inflammatory bowel disease patient. (Q34234668) (← links)
- Succession in the gut microbiome following antibiotic and antibody therapies for Clostridium difficile (Q34447678) (← links)
- The roles of host and pathogen factors and the innate immune response in the pathogenesis of Clostridium difficile infection (Q34623572) (← links)
- A Multi-Center Prospective Derivation and Validation of a Clinical Prediction Tool for Severe Clostridium difficile Infection (Q35532908) (← links)
- Clostridium difficile toxin B intoxicated mouse colonic epithelial CT26 cells stimulate the activation of dendritic cells. (Q35619086) (← links)
- Fecal microbiota transplantation for Clostridium difficile infection: back to the future. (Q35660581) (← links)
- Recurrent Clostridium difficile infection: From colonization to cure (Q35822541) (← links)
- Breakthroughs in the treatment and prevention of Clostridium difficile infection (Q35918566) (← links)
- Profiling Humoral Immune Responses to Clostridium difficile-Specific Antigens by Protein Microarray Analysis (Q35998772) (← links)
- Structural and functional changes within the gut microbiota and susceptibility to Clostridium difficile infection. (Q36018079) (← links)
- Clostridium difficile toxins: mediators of inflammation. (Q36072072) (← links)
- Assessing the effect of patient screening and isolation on curtailing Clostridium difficile infection in hospital settings (Q36391688) (← links)
- Host Immune Response to Clostridium difficile Infection in Inflammatory Bowel Disease Patients (Q36689391) (← links)
- Human monoclonal antibodies against Clostridium difficile toxins A and B inhibit inflammatory and histologic responses to the toxins in human colon and peripheral blood monocytes (Q36969841) (← links)
- Markers of intestinal inflammation, not bacterial burden, correlate with clinical outcomes in Clostridium difficile infection (Q36999988) (← links)
- The Clostridium difficile Dlt Pathway Is Controlled by the Extracytoplasmic Function Sigma Factor σV in Response to Lysozyme (Q37002320) (← links)
- Diagnosis of Clostridium difficile infection: an ongoing conundrum for clinicians and for clinical laboratories (Q37035829) (← links)
- Genetic risk factors for Clostridium difficile infection in ulcerative colitis (Q37125998) (← links)
- Clostridium difficile infection in the twenty-first century (Q37289567) (← links)
- Clostridium difficile in a HIV-infected cohort: incidence, risk factors, and clinical outcomes (Q37432696) (← links)
- Immunization strategies for Clostridium difficile infections (Q38006996) (← links)
- Interaction between the intestinal microbiota and host in Clostridium difficile colonization resistance (Q38010864) (← links)
- Risk factors for the development of Clostridium difficile colitis in a surgical ward (Q38026052) (← links)
- Clostridium difficile in foods and animals: history and measures to reduce exposure (Q38074514) (← links)
- New drugs and strategies for management of Clostridium difficile colitis (Q38113471) (← links)
- Review article: intestinal barrier dysfunction and central nervous system disorders--a controversial association (Q38254985) (← links)
- Bezlotoxumab: anti-toxin B monoclonal antibody to prevent recurrence of Clostridium difficile infection (Q38668483) (← links)
- Mucosal Antibodies to the C Terminus of Toxin A Prevent Colonization of Clostridium difficile (Q38717600) (← links)
- Cytokines Are Markers of the Clostridium difficile-Induced Inflammatory Response and Predict Disease Severity. (Q38737485) (← links)
- Clostridium difficile infection: epidemiology, diagnosis and understanding transmission (Q38765888) (← links)
- Neutrophil-mediated inflammation in the pathogenesis of Clostridium difficile infections (Q38804174) (← links)
- Nosocomial Clostridium difficile-associated diarrhoea in Assiut University Children's Hospital, Egypt (Q38858517) (← links)
- Host response to Clostridium difficile infection: Diagnostics and detection (Q38969987) (← links)
- Defining the optimal formulation and schedule of a candidate toxoid vaccine against Clostridium difficile infection: A randomized Phase 2 clinical trial (Q39889958) (← links)
- Healthcare-Associated Clostridium difficile Infections are Sustained by Disease from the Community. (Q40106953) (← links)
- Strategies for Optimizing the Diagnostic Predictive Value of Clostridium difficile Molecular Diagnostics (Q40302301) (← links)
- Predicting the risk for hospital-onset Clostridium difficile infection (HO-CDI) at the time of inpatient admission: HO-CDI risk score (Q41264025) (← links)
- Development of microbeads of chicken yolk antibodies against Clostridium difficile toxin A for colonic-specific delivery (Q41394134) (← links)
- Protective role of commensals against Clostridium difficile infection via an IL-1β-mediated positive-feedback loop (Q41892852) (← links)
- Clostridium difficile infection: new approaches to prevention, non-antimicrobial treatment, and stewardship (Q41990887) (← links)
- The vermiform appendix and recurrent Clostridium difficile infection: a curious connection (Q42320412) (← links)
- Neutralization of Clostridium difficile Toxin B Mediated by Engineered Lactobacilli That Produce Single-Domain Antibodies (Q42697422) (← links)